| 英語名 | 研究コード | 研究開発ステージ | 会社 | 適応症 | 臨床試験 |
|---|---|---|---|---|---|
| Olaptesed Pegol | NOX-A12 | Phase 2 Clinical | Noxxon Pharma | Colorectal Neoplasms; Glioblastoma; Hematopoietic stem cell transplantation (HSCT); Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma; Pancreatic Neoplasms | 詳細 |
| PTX-9908 | PTX-9908 | Phase 2 Clinical | Pertinax Therapeutics | Carcinoma, Hepatocellular | 詳細 |
| JVS-100 | JVS-100; SRX-100; ACRX-100; GP-51801; GP51801 | Phase 1 Clinical | Cleveland Clinic | Heart Failure; Ischemia; Peripheral Arterial Disease; Surgical Wound | 詳細 |
| CK-0804 | CK-08041; CK-0804 | Phase 1 Clinical | Cellenkos Inc | Primary Myelofibrosis | 詳細 |
| MyoCell SDF-1 | MyoCell SDF-1 | Clinical | U.S. Stem Cell | Heart Failure | 詳細 |